Pathophysiology
Abnormality | Incidence |
Trisomy 21 | 95% |
Chromosomal translocation | 4% |
Mosaic trisomy 21 | 1% |
Diagnosis
- Ante-natal screening is offered routinely during pregnancy, combining:
- A blood test
- Ultrasound screening for nuchal translucency
- Screening occurs between 10 and 20 weeks gestation
- Those with higher-chance results are offered amniocentesis or chorionic villus sampling
- Post-natal confirmatory diagnosis involves testing using a patient blood sample (chromosomal karyotype)